StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of DBV Technologies in a research report on Wednesday, February 21st. View […]
StockNews.com started coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the stock. Separately, HC Wainwright reissued a “buy” rating and set a $10.00 target price on shares of DBV Technologies in a research report on Wednesday, February 21st. […]
DBV Technologies (NASDAQ:DBVT – Get Free Report) and Vigil Neuroscience (NASDAQ:VIGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, dividends and profitability. Analyst Ratings This is a breakdown of […]
Stock analysts at StockNews.com began coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock. Separately, HC Wainwright reissued a “buy” rating and issued a $10.00 target price on shares of DBV Technologies in a research report […]
StockNews.com started coverage on shares of DBV Technologies (NASDAQ:DBVT – Free Report) in a research report released on Saturday. The brokerage issued a hold rating on the stock. DBVT has been the subject of several other reports. HC Wainwright reissued a buy rating and issued a $10.00 target price on shares of DBV Technologies in […]